STAT August 5, 2024
John Wilkerson

WASHINGTON — Medicare officials are offering private insurers big subsidies to keep premiums for prescription-drug plans stable as the elections approach.

The Inflation Reduction Act, passed by Democrats in 2022, made several changes to Medicare’s drug benefit, known as Medicare Part D. All were aimed at lowering drug prices and drug costs for both seniors and the federal government. The most well-known policies cap annual out-of-pocket drug costs for seniors,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
Medicare Part D in 2025: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes
RFK Jr. eyes overhaul of Medicare physician pay: What to know
CMS awards third round of Medicare-funded residency slots to hospitals

Share This Article